Natalizumab: a new hope for Crohn's disease?

Am J Gastroenterol. 2003 May;98(5):1197-9. doi: 10.1111/j.1572-0241.2003.07463.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • C-Reactive Protein / analysis
  • Crohn Disease / blood
  • Crohn Disease / drug therapy*
  • Double-Blind Method
  • Humans
  • Infusions, Intravenous
  • Natalizumab
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • C-Reactive Protein